EASD 2024: The Impacts of Automated Insulin Delivery and CGMs
This week, T1D Exchange attended the 60th European Association for the Study of Diabetes (EASD) Annual Meeting in Madrid, Spain….
Glucagon for Emergencies and its Potential for Everyday Use
Insulin is a key player in regulating blood glucose (BG), but it doesn’t act alone. Another hormone called glucagon plays…
T1D Exchange at ADCES24: Perceived Support for Anxiety and Depression, Reducing Inequities, and Creating More Personal Clinic Visits for T1D
T1D Exchange attended the Association of Diabetes Care & Education Specialists (ADCES) conference in New Orleans, LA, August 9-12, 2024,…
Work from the T1D Exchange Quality Improvement Collaborative in the Spotlight at the ADA’s 84th Scientific Sessions
T1D Exchange was honored to join top scientists, providers, and industry experts in the diabetes space from June 21-24 at…
Ask-a-Scientist: All About Autoimmunity & Type 1 Diabetes
Welcome to the first of our Ask-a-Scientist Series! A few weeks ago, we posed a question to our Online Community:…
The Color of Your Skin Should Not Affect Your Diabetes Care
The color of a person’s skin should not affect their diabetes care, but it still does. Despite so many advancements…
Our Research: Your Mental Health with T1D Should Be Part of Routine Healthcare
Editor’s Note: If you are experiencing thoughts of self-harm or suicidal ideation, text the word “NAMI” to the National Alliance…
Reaching A1c Goals: Research Says These Factors Matter Most
Your HbA1c (A1c) is one part of your toolkit as a person with type 1 diabetes (T1D). This number cannot…
FDA Approves First Drug to Delay the Full Onset of Type 1 Diabetes
The FDA approval of teplizumab — brand name Tzield — was announced today on November 17, 2022 for use in people…
Where to Find T1D Exchange at ADA’s 81st Scientific Sessions
The American Diabetes Association’s (ADA) 81st Scientific Sessions are right around the corner, and T1D Exchange is thrilled to be among the many…
